DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Bhatt DL, Topol EJ. , on behalf of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization Management and Avoidance Executive Committee
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (CHARISMA) trial
Am Heart J 2004; 148: 263-268
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.